• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    B. Braun Issues Voluntary Recall of Lactated Ringer’s Injection

    FDA

    Lexia’s Receives FDA Warning Letter

    FDA

    Intas’ Receives FDA Warning Letter

    FDA

    Enforcement Report - Week of April 22, 2026

    FDA

    Par Health’s Receives FDA Warning Letter

    FDA

    RC Outsourcing’s Receives FDA Warning Letter

    FDA

    UCSF Radiopharmaceutical Facility’s Receives FDA Warning Letter

    FDA

    Apollo Care’s Receives FDA Warning Letter

    FDA

    Xiamen Kang Zhongyuan Biotechnology’s Receives FDA Warning Letter

    FDA

    Thrive Health and Wellness’ Receives FDA Warning Letter

    FDA

    Produlab Pharma Production Fails EDQM Inspection

    EMA

    Veyx-Pharma B.V. Production Fails EDQM Inspection

    EMA

    Cabio Biotech Wuhan is on FDA Import Alert List

    FDA

    Swiss Parenterals Limited Production Fails EDQM Inspection

    EMA

    Enforcement Report - Week of April 15, 2026

    FDA

    Peyrano Torino Is on FDA Import Alert List

    FDA

    Gomar Pinczow Sp. z o.o. SKA Is on FDA Import Alert List

    FDA

    Fffood Sp. Z.o.o. Is on FDA Import Alert List

    FDA

    Rafael Dybvik Is on FDA Import Alert List

    FDA

    Pure Indulgence Aesthetics’ Receives FDA Warning Letter

    FDA

    Blaine Labs Issues Voluntary Nationwide Recall of Wound Care Gel

    FDA

    Enforcement Report - Week of April 8, 2026

    FDA

    Ehsan Sadri’s Receives FDA Warning Letter

    FDA

    Huons Co. is on FDA Import Alert List

    FDA

    Enforcement Report - Week of April 1, 2026

    FDA

    Sun Pharma Fails EDQM Inspection

    EMA

    IDO PHARM is on FDA Import Alert List

    FDA

    Eugia Pharma Fails EDQM Inspection

    EMA

    FDA Issues Form 483 to Revive Rx

    FDA

    Macau-Union Pharmaceutical is on FDA Import Alert List

    FDA

    Amneal Issues Voluntary Nationwide Recall of Magnesium Sulfate

    FDA

    Yangzhou H&R Plastic Daily Chemical’s Receives FDA Warning Letter

    FDA

    4U Health’s Receives FDA Warning Letter

    FDA

    Cardinal Health Issues Voluntary Nationwide Recall of Webcol

    FDA

    Xiamen Kang Zhongyuan Biotech is on FDA Import Alert List

    FDA

    Erkul Kozmetik Sanayi is on FDA Import Alert List

    FDA

    Patcos Cosmetics’ Receives FDA Warning Letter

    FDA

    Apothecary Pharma’s Receives FDA Warning Letter

    FDA

    Flowchem Pharma’s Receives FDA Warning Letter

    FDA

    OraLabs’ Receives FDA Warning Letter

    FDA

    Vedic Lifesciences’ Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to BayCare Integrated Service Center

    FDA

    Enforcement Report - Week of March 11, 2026

    FDA

    FDA Issues Form 483 to VET4U

    FDA

    Tentamus’ Receives FDA Warning Letter

    FDA

    Fareva Morton Grove’s Receives FDA Warning Letter

    FDA

    NSE Products’ Receives FDA Warning Letter

    FDA

    Simtra BioPharma Solutions’ Receives FDA Warning Letter

    FDA

    Novo Nordisk’s Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to Novo Nordisk

    FDA

    Halewood Lab Fails EDQM Inspection

    EMA

    FDA Issues Form 483 to Maiva Pharma

    FDA

    Enforcement Report - Week of March 4, 2026

    FDA

    GenoGenix’s Receives FDA Warning Letter

    FDA

    Harbin Jixianglong Biotech is on FDA Import Alert List

    FDA

    A Nelson & Co’s Receives FDA Warning Letter

    FDA

    A. Nelson & Co.’s Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to Aurobindo Pharma Limited, Unit VII

    FDA

    FDA Issues Form 483 to Eugia Pharma Specialities Limited

    FDA

    Enforcement Report - Week of February 18, 2026

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.